Behind-the-counter status and availability of emergency contraception.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 18554568.
- Also identified by DOI 10.1016/j.ajog.2008.04.032.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of the study was to determine whether the 2006 Food and Drug Administration approval of Plan B for behind-the-counter status increased availability. We conducted a survey in 2005 and 2007 of pharmacies listed in Atlanta, GA, Boston, MA, and Philadelphia, PA. We measured ability to dispense Plan B within 24 hours. Also measured were reasons for lack of availability and cost of Plan B. Pharmacists were interviewed at 1087 pharmacies (75% response rate) in 2005 and 795 pharmacies (82% response rate) in 2007. In 2007, 8% of pharmacies were unable to provide Plan B within 24 hours, compared with 23% of pharmacies in 2005 (P < .001). The total refusal rate in 2007 was half the rate of 2005 (2% vs 4%, P = .004). The average cost of Plan B was $43. Availability of Plan B in Atlanta and Philadelphia increased after it was awarded behind-the-counter status.
Medical subject headings
- Contraception, Postcoital
- Contraceptive Agents, Female
- Contraceptives, Oral, Synthetic
- Levonorgestrel
- Nonprescription Drugs